Literature DB >> 19386530

A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient.

A Beltrame1, L Sarmati, L Cudillo, R Cerretti, A Picardi, L Anemona, C Fontana, M Andreoni, W Arcese.   

Abstract

A fatal case of Scopulariopsis acremonium sinus infection in an allogeneic hematopoietic stem cell transplant patient is reported. Rapid vascular diffusion of the fungus to the major head vessels was observed, which led to subsequent repeated cerebral ischemia and death. The presence of hyphae in the right carotid wall might be considered an indirect sign of fungal blood diffusion in the absence of positive blood cultures. The infection developed during the course of prolonged voriconazole prophylaxis, which was found to be effective in the in vitro antifungal drug assay. This finding induced us to consider the capacity of this drug to reach infected paranasal sinuses, and the need in cases such as this of a combined systemic and local pharmacological therapy or a combined medical and surgical approach.

Entities:  

Mesh:

Year:  2009        PMID: 19386530     DOI: 10.1016/j.ijid.2009.01.020

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  8 in total

1.  Scopulariopsis, a poorly known opportunistic fungus: spectrum of species in clinical samples and in vitro responses to antifungal drugs.

Authors:  Marcelo Sandoval-Denis; Deanna A Sutton; Annette W Fothergill; Josep Cano-Lira; Josepa Gené; C A Decock; G S de Hoog; Josep Guarro
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

Review 2.  Acremonium kiliense: case report and review of published studies.

Authors:  Milton Camplesi Júnior; Adriano de Moraes Arantes; Hildene Meneses Silva; Carolina Rodrigues Costa; Maria do Rosário Rodrigues Silva
Journal:  Mycopathologia       Date:  2013-09-04       Impact factor: 2.574

3.  Invasive Scopulariopsis alboflavescens infection in patient with acute myeloid leukemia.

Authors:  Keiji Kurata; Sho Nishimura; Hiroya Ichikawa; Rina Sakai; Yu Mizutani; Kei Takenaka; Seiji Kakiuchi; Yoshiharu Miyata; Akihito Kitao; Kimikazu Yakushijin; Shinichiro Kawamoto; Katsuya Yamamoto; Mitsuhiro Ito; Hiroshi Matsuoka; Issei Tokimatsu; Katsuhiko Kamei; Hironobu Minami
Journal:  Int J Hematol       Date:  2018-07-09       Impact factor: 2.490

4.  Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.

Authors:  Charline Miossec; Florent Morio; Thierry Lepoivre; Patrice Le Pape; Dea Garcia-Hermoso; Françoise Gay-Andrieu; Alain Haloun; Michele Treilhaud; François Leclair; Michel Miegeville
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

5.  Invasive Microascus trigonosporus Species Complex Pulmonary Infection in a Lung Transplant Recipient.

Authors:  Kelly E Schoeppler; Martin R Zamora; Noelle M Northcutt; Gerard R Barber; Gayle O'Malley-Schroeder; Dennis M Lyu
Journal:  Case Rep Transplant       Date:  2015-05-14

6.  21-year retrospective study of the prevalence of Scopulariopsis brevicaulis in patients suspected of superficial mycoses.

Authors:  Anna B Macura; Magdalena Skóra
Journal:  Postepy Dermatol Alergol       Date:  2015-06-15       Impact factor: 1.837

7.  First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling.

Authors:  Xuebin Tian; Qiongdan Wang; Laura Perlaza-Jiménez; Xiangkuo Zheng; Yajie Zhao; Vijay Dhanasekaran; Renchi Fang; Jiahui Li; Chong Wang; Haiyang Liu; Trevor Lithgow; Jianming Cao; Tieli Zhou
Journal:  BMC Microbiol       Date:  2020-07-20       Impact factor: 3.605

8.  Sinusitis caused by Scopulariopsis brevicaulis: Case report and review of the literature.

Authors:  Laurent Sattler; Marcela Sabou; Amina Ganeval-Stoll; Caroline Dissaux; Ermanno Candolfi; Valérie Letscher-Bru
Journal:  Med Mycol Case Rep       Date:  2014-06-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.